StrategyR is a trade mark of Global Industry Analysts, Inc. USA
A trade mark of Global Industry Analysts, Inc.
Global Market Trajectory & Analytics
VALIDATED EXECUTIVE ENGAGEMENTS
Number of executives repeatedly engaged by snail & email outreach*
POOL + OUTREACH
Interactions with Platform & by Email *
Unique # Participated *
Responses Validated *
* Login to view program details and full enterprise executive list.
GLOBAL EXECUTIVE SURVEY
Impact of Pandemic & Economic Slowdown
Monitor Market Dynamics! Early March 2020, we reached out to senior enterprise executives who are driving strategy, business development, marketing, sales, product management, technology and operations at competitive firms worldwide. Our ongoing survey is focused on how this will this affect their business ecosystems. We invite you to participate in our survey and add to collective perspectives. Market movements are tracked for 2020, 2021 and broadly for the period of 2022 through 2025. Critical changes are monitored dynamically for the rest of this year. Updated analytics will reflect new and evolving market realities. Our first update scheduled for May 2020 and another in the Fall. Clients receive complimentary updates during 2020. If your company is a recent client for this project, we may have already reached out to your colleagues to participate in our program. If you're an active player in the space but hasn't yet subscribed to our project, we invite you to participate and share your perspectives. Please sign-up here.
Always driven by epidemics and pandemics, the global market for Medical Gloves is projected to reach US$70 billion by 2027, trailing a CAGR of 12.4% during the analysis period 2020 through 2027. The novel corona virus spreading rapidly across the globe is by far the worst and the most deadly pandemic in recent history with death tolls surpassing that of MERS (850) and SARS (770). The death toll currently stands at 561,617and continues to rise at alarming speeds. As the health crisis continues to deepen, the world is scrambling to meet a critical shortage of protective wear. With studies proving gloves to be effective in protecting against covid-19, what the world needs now are medical gloves. Over 80 million gloves are needed by COVID-19 health response teams each month worldwide. Over 45% increase in personal protective equipment (PPE) production is needed to meet the world's rising demand to fight the pandemic. A frightening crisis is now unfolding, as growing numbers of frontline healthcare workers get infected due to shortage of protective gear. As a result per capita consumption of medical gloves, especially examination gloves is expected to witness a sudden temporary spike as the pandemic continues to ravage the world. As distressed governments float global tenders for PPE equipment, glove manufacturers are being pushed into overdrive as they struggle to meet the spike in demand. Top Glove Corporation, the world's largest manufacturer of medical gloves, is modifying its production lines to meet increased demand and close the demand and supply gap. Disruptions nevertheless are creating serious risks with companies grappling with massive shortage of workers. Staging an early recovery from the pandemic, China's restarting of medical supplies production for global exports offers hope in easing the pressure at least partially. Under this scenario of changing dynamics, the market is ready for significant upward revision in growth forecasts in the short-term.
Gloves are one of the most important safety products used by medical and health personnel. Healthcare staff used gloves for the first time in the year 1889. Since then the market has been driven by the growing virulence of hard-to-treat infectious diseases like Hepatitis B virus (HBV) and human immunodeficiency virus (HIV), and growing awareness among care givers over the healthcare-associated risks of viral and bacterial infections. Other evergreen growth factors in the market include aging population and spiraling rise in the number of surgeries and medical examinations performed; increasing emphasis on the use of disposable gloves from government and non-government agencies; stringent implementation of infection-control programs to prevent the risk of disease transmission in hospitals and clinics; focus on reducing healthcare costs associated with nosocomial infections and morbidity rates; emphasis on reducing hospital stays; implementation of 'double gloving' practice to reduce the risk of exposure to patients' blood; and migration from reusable to disposable medical supplies supported by evolving recycling options that reduce environmental concerns. Also shaping growth will be technology innovations such as nitrile-based glove coatings and hypoallergenic polyisoprene engineered to provide superior barrier protection without the risk of latex allergies; and development and launch of gloves optimized for complex surgeries and designed to offer the best protection without sacrificing physician dexterity while simultaneously enhancing tactile sensitivity.
» Segment (Examination Gloves, Surgical Gloves) » End-Use (Hospitals & Clinics, Ambulatory Surgery Centers, Other End-Uses)
» World » USA » Canada » Japan » China » Europe » France » Germany » Italy » UK » Spain » Russia » Rest of Europe » Asia-Pacific » Australia » India » South Korea » Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » UAE » Rest of Middle East » Africa
INSIDER ACCESS PRIVILEGES
Users of our portal have insider access to our data stacks based on project relevance and engagement status. Tiered access is offered to data stacks, managed based on user status - Opt-in, Active Panelist, Inactive Panelist, Active Client or Inactive Client.
Registration is required to access our data stacks.
We are firmly committed to build upon perspectives from global executive insights. These engagements enrich our projects. Our primary research programs are fully validated and accessible by clients. (Its a common industry-wide* practice that no validated primary research is done! For the most part, remote resident analysts curate and write reports drawing on search engine research and data modeling.)
* A review of 262 off-the-shelf market report publishers worldwide.
WHAT SETS US APART Client companies can access multiple features on our MarketGlass™ platform.
Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.
Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)
A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.
Where relevent and possible we present competitive brands.
Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.
Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.
Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.
We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.
Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.
All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.
EXPERT PANEL REGISTRY
We're excited to add you to our Domain Expert Panel! Let's get you started.
*All fields are mandatory.
YOUR PRIVACY MATTERS TO US!
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates. What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank. How we store: Encrypted and additionally secured by firewalls. How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.